Victor Weigman, Ph.D. | May 18, 2016

Expanding Treatment Options with Genomics-Enabled Immuno-Oncology

Tumor genomic profiling can direct patients to new therapeutic possibilities. Positive responses aside, many patients are left with few treatment options. Download this presentation to learn how genomics can further illuminate the inherently complex tumor microenvironment – with beneficial implications for immuno-oncology strategies and the future of genomic testing for cancer treatment.

Victor Weigman, Ph.D., Director, Translational Genomics

Related Services:
Gene expression for keeping pace with immuno-oncology breakthroughs and biomarker identification

When and how to use gene expression profiling

Precision medicine: Shifting from one drug for all patients to personalized genomics-based therapeutic options

Read More